| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | US20040058856 Fusion protein; efficient transduction; penetration of cell membrane |
| 03/25/2004 | US20040058416 Human trk receptors and neurotrophic factor inhibitors |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040057960 Activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells, using fusion proteins comprising HCV, NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins; immunogens |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057902 For use in diagnosis and therapy |
| 03/25/2004 | CA2499221A1 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | CA2499214A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2497226A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 03/24/2004 | EP1400536A1 Method for making humanized antibodies |
| 03/24/2004 | EP1399589A2 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399556A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399545A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 03/24/2004 | EP1399475A2 Mutants of igf binding proteins and methods of production of antagonists thereof |
| 03/24/2004 | CN1484698A Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1483737A Specific protein of SARS virus, clinical detection method and kit |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142941C Cells bearing CD4 decoy receptors and related molecules and methods |
| 03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709838 Nucleic acid encoding patched-2 |
| 03/23/2004 | US6709821 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/23/2004 | CA2336207C Ecdysone receptors and methods for their use |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022600A1 Secretory or membrane-binding chimeric protein |
| 03/18/2004 | WO2004022599A1 Fused antibody and method of constructing the same |
| 03/18/2004 | WO2004022598A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | US20040055022 Compositions and methods for screening therapeutic agents |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054137 Chimeric protein for diagnosis and treatment of cancers and infections; immunotherapy |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053372 Comprises prothrombin amino acid sequences for treating thrombosis and blood disorders |
| 03/18/2004 | US20040053370 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053296 Method for localizing polypeptide on cell surface |
| 03/18/2004 | US20040052816 Recombinant protective protein from streptococcus pneumoniale |
| 03/18/2004 | US20040052813 Polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits and the diagnostic kits |
| 03/18/2004 | US20040052812 Immunogenic complex containing a multi-component viral particle covalently linked to a javelin molecule, wherein the javelin molecule is a peptide which selectively binds to a heat shock protein |
| 03/18/2004 | CA2497873A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2497696A1 Increasing the absorption of substances via the skin and mucous membranes |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/17/2004 | EP1397492A2 Modified and stabilized gdf propeptides and uses thereof |
| 03/17/2004 | EP1397484A2 Methods and products related to fgf dimerization |
| 03/17/2004 | EP1397386A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 03/17/2004 | EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 03/17/2004 | EP0952981B1 Method for producing a correctly folded, biological active recombinant protein |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | CN1483041A GLP-1 fusion protein |
| 03/17/2004 | CN1481899A Novel vaccine of tumor antigen, its preparation method and vaccine composition |
| 03/17/2004 | CN1142183C Anti-idiotype microantibody and its preparing process and application |
| 03/16/2004 | US6706762 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases |
| 03/16/2004 | US6706496 Method for expression of heterologous proteins in yeast |
| 03/16/2004 | CA2234204C Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same |
| 03/16/2004 | CA2136961C Bnp antibody and immunoassay using it |
| 03/11/2004 | WO2004020639A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | WO2004020404A2 Modified transferin-antibody fusion proteins |
| 03/11/2004 | WO2004007544A3 Components of the presenilin-complex |
| 03/11/2004 | WO2004007525A3 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003055974A3 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2002101026A8 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |